botulinum toxin type A

(redirected from Botox Cosmetic)

bot·u·li·num tox·in type A

(boy'yū-lī'nŭm tok'sin tīp)
A biological used as an anesthetic and in cosmesis (with sometimes unsettling results).

botulinum toxin type A

A neuromuscular blocking drug used to paralyze muscles, esp. muscles in spasm. It is also used for cosmetic purposes, e.g., by those desirous of maintaining a fixed facial appearance.
See also: toxin
References in periodicals archive ?
He has established a strong reputation for his talent in administering dermal fillers, BOTOX Cosmetic and Dysport injections, and Fraxel laser treatments and is a national trainer for Allergan.
The NDS platform technology and ANT-1207 add to Allergan's strong neurotoxin pipeline, with BOTOX Cosmetic (onabotulinumtoxinA) currently in development for treating forehead lines, masseter hypertrophy and platysma bands and BOTOX Therapeutic in development for osteoarthritis and depression.
For nearly 13 years, until the introduction of botox cosmetic in 2002, the only FDA-approved uses of botox were for strabismus and blepharospasm.
Of these, Botox Cosmetic, made up approximately half of all minimally invasive procedures performed, followed by hyaluronic acid and peels.
Brands such as Allergan's Botox Cosmetic and Juvederm have been essentially synonymous with injectables since their introduction, and will continue to lead growth going forward.
Labels for Botox and Botox Cosmetic contain a boxed warning stating that botulinum toxin may spread from the injection site and cause potentially life-threatening symptoms--including difficulty swallowing and breathing--that resemble botulism.
Gilman notes the Era of Glamour started with the Botox Cosmetic Revolution, during which nonsurgical options to diminish facial lines became accessible, affordable, and provided a natural, relaxed look without the long recovery time of cosmetic surgery.
The warning will go on all approved botulinum toxins: Botox and Botox Cosmetic (both type A, Allergan), the just-approved type A product Dysport (Medicis and Ipsen), and the botulinum toxin type B product Myobloc (Solstice Neurosciences).
The warning will go on all approved botulinum toxins: Botox and Botox Cosmetic (both type A, Allergan); the just-approved type A product Dysport (Medicis and Ipsen); and the botulinum toxin type B product Myobloc (Solstice Neurosciences).
2 billion in 2007 with its wrinkle-reducing botox cosmetic.
In a statement, Allergan emphasized that there had been no deaths associated with Botox cosmetic use.
Botox Cosmetic is FDA-approved to smooth unsightly wrinkles between the eyebrows, a condition called a fettered, or furrowed, brow.